MOTS-c
Also known as Mitochondrial open reading frame of the 12S rRNA-c
Sold as exercise in a vial. FDA could not find a single human safety study, and the US rule change in October 2026 is about supply, not proof.
Information only. Not medical advice. Talk to a doctor before you start, stop or change anything.
What people claim
- Exercise in a vial
- Burns fat and fixes insulin resistance
- Natural, because the body makes it
Known risks
- FDA says potential safety risks in humans are unknown, and flags possible immune reactions.[1]
- People who buy it online report fast heart rate or palpitations, injection site irritation, insomnia, immune reactions and fever.[2]
- TGA says it has not evaluated these products and that supplying unapproved peptides is unlawful.[4]
Reported side effects
Moderated user reports are not open yet, so nothing is shown here. They will be labelled as unverified personal accounts.
Legal status
A summary, not legal advice. Rules change, and sport bans are separate.
Unapproved, compounding tolerated
An interim HHS policy from 28 Oct 2026 lets licensed compounding pharmacies supply it on a patient-specific prescription. It is not FDA approval.[3]
Unlicensed
No MHRA-licensed medicine contains it.
Not approved
TGA says importing, advertising or supplying unapproved peptides is unlawful.[4]
Not authorised
No authorised medicine. National rules on possession and import differ.
Sources
- 1.FDA evaluation of MOTS-c bulk drug substances (Pharmacy Compounding Advisory Committee briefing)US FDA, 2026
- 2.What is the MOTS-c peptide?US Anti-Doping Agency
- 3.HHS interim enforcement discretion policy for six peptides (legal summary)Holland & Knight, Nov 2026
- 4.Importing, compounding and supplying unapproved peptide productsTGA Australia
Profile last checked 7 Nov 2026.